Navigation Links
VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer
Date:7/3/2011

Meyer on July 7, 2011 from 9:30am-12:30pm CEST.  

The IASLC's 14th World Conference on Lung Cancer is being held in Amsterdam, the Netherlands from July 3-July 7, 2011.  For more information, visit www.2011worldlungcancer.org/

About the International Association for the Study of Lung Cancer (IASLC)Founded in 1972, the International Association for the Study of Lung Cancer (IASLC) is an international organization of nearly 3,000 lung cancer specialists spanning 80 countries. IASLC members work towards developing and promoting the study of etiology, epidemiology, prevention, diagnosis, treatment and all other aspects of lung cancer and other thoracic malignancies. IASLC's mission is to enhance the understanding and education of lung cancer to scientists, members of the medical community and the public. In addition to the biannual meeting, the IASLC publishes the Journal of Thoracic Oncology, a prized resource for medical specialists and scientists who focus on the detection, prevention, diagnosis and treatment of lung cancer.

About VisionGateVisionGate, Inc. is developing a revolutionary non-invasive test for the early detection of lung cancer, using its automated 3D cell imaging platform, the Cell-CT™, which generates high-resolution 3D biosignatures from intact cells using a sputum sample.  The company's LuCED™ test is initially being developed for adjunctive use with low dose x-ray computed tomography (CT) screening for the early detection of lung cancer in high risk individuals.  Adjunctive use of LuCED to better manage the high rate of false positive results in CT screening could increase the utility and cost effectiveness of the approach, which has been shown to decrease lung cancer deaths in former and current smokers.  For more information, visit www.visiongate3D.com.VisionGate  

MediaScarlett
'/>"/>

SOURCE VisionGate, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. CardioFocus HeartLight™ Endoscopic Ablation System Enables Treatment of Atrial Fibrillation: Live Case and Abstract Presented at EHRA EUROPACE 2011
2. Lexicon Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
3. Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011
4. Analysis Shows BYDUREON™ Was Not Associated with Clinically Relevant QT Prolongation in Patients with Type 2 Diabetes: Results Presented at ADA 2011
5. Analysis Finds BYETTA® Associated with Lower Likelihood of Heart Failure Compared with Other Diabetes Therapies: Results Presented at ADA 2011
6. Positive Results for Investigational Compound Lyxumia® (Lixisenatide) Presented at American Diabetes Associations 71st Annual Scientific Sessions
7. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Presents at 6th Annual Executive Forum on Pharmacy Benefit Management Strategies
8. PharmacoFore, Inc. Announces Positive Results from a Phase I Clinical Study of Its Hydromorphone Bio-Activated Molecular Delivery™ System, and Upcoming Presentation at the 2011 BIO Business Forum During the Annual BIO International Convention in Was
9. MAP Pharmaceuticals to Present Data on LEVADEX® at the 15th Congress of the International Headache Society
10. MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28
11. Asmacure Ltee to Present at the 2011 BIO Business Forum During the Annual BIO International Convention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Mass. , May 23, 2013  Haemonetics Corporation (NYSE: ... Lindop , CFO & EVP-Business Development, will present at ... Conference in Boston, MA on May ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may access ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)...  MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
(Date:5/23/2013)... Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly ... property developed and owned by Hadassah University Hospital, ... center, today announced that its portfolio company, Cell ... Israeli Ministry of Industry and Commerce, Office of ... and advance clinical trials. Cell Cure,s development budget ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... Oct. 28 Octapharma Group and Fresenius Kabi ... regarding the use of Fresenius Kabi,s HESylation® Technology ... the agreement, Fresenius Kabi will license its proprietary ... based on hydroxyethyl starch ("HES") which will be ...
... , MALVERN, Pa., Oct. 28 Featuring the lowest ... Siemens Healthcare,s SOMATOM® Definition Flash dual-source computed tomography (CT) ... for Children, Orlando, Fla., to better serve its pediatric ... of the radiation dose that systems previously required to ...
Cached Medicine Technology:Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 2Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein 3Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 2Siemens Delivers Flash Speed, Lowest Dose to Arnold Palmer Hospital for Children 3
(Date:5/24/2013)... Mirena IUD lawyers at the Rottenstein Law Group are ... than 59,229 complaints since 2004 from women claiming they suffered ... as the Mirena IUD.* , Among the most common of ... where the IUD came out on its own. There are ... article. “Abdominal pain is also common, with 3,774 complaints. And ...
(Date:5/24/2013)... 24, 2013 Gift Card Network ... competitors in sustainable card material, are combining forces ... materials as a sustainable gift card substrate. , ... industry challenges and increase education and usage of ... support the reduction of carbon footprint and environmental ...
(Date:5/24/2013)... failed to replicate what appeared to be breakthrough results ... were published last year in the journal Science ... suggested that the drug bexarotene (marketed as Targretin) could ... a pathological hallmark of Alzheimer,s disease in ... the 2012 report, drug treatment quickly removed most of ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
(Date:5/24/2013)... 24, 2013 Mike Stoler believes that ... successful business people in New York. That’s why ... weekly on CUNY TV. And that’s why he ... Allergy Associates, LLP (ENTA)—the largest single specialty practice in ... throat, allergy and audiology specialists and sub-specialists service communities ...
Breaking Medicine News(10 mins):Health News:Sufferers of Alleged Mirena IUD Side Effects Lodge More Than 59,000 Complaints With FDA, Rottenstein Law Group LLP Notes 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4
... 30 Military Officers Association of America ... (Ret), pulled no punches in expressing MOAA,s objection to ... inpatient copays by $110 per day for retired servicemembers, family ... and extremely disappointed that there would be any copay increase ...
... at UCSF Medical Center have begun enrollment for an early-stage ... adult stem cell therapy for patients who have just experienced ... is part of a multi-center national study. The cells ... bone marrow of healthy adult donors. Depending on their location ...
... it lowered risk of neurological problems later , WEDNESDAY, Sept. ... body temperature of oxygen-deprived newborns reduces the risk for neurological ... risk of death or severe disability. , Still, the findings, ... England Journal of Medicine , help fill a crucial gap ...
... ... Jonathan Kraft , ... (Vocus) September 30, 2009 -- The Boston biotechnology industry will get an early look at ... October 27, 2009 at Harvard Medical School. , , ,At the one-day event, recently funded ...
... Simmons firm, a leading national law firm in the fight ... Miles for Meso 5K run/walk on Sunday, October 11, in ... www.milesformeso.org . , The Simmons firm ... in Alton, Ill. Nearly 500 runners and walkers registered, and ...
... DALLAS, Sept. 30 The Sleep Center at Baylor University ... American Academy of Sleep Medicine. The center at Baylor ... in North Texas. , "Accreditation provides formal recognition ... for patients suffering from sleep disorders," said David L. ...
Cached Medicine News:Health News:MOAA Decries 21% TRICARE Inpatient Copay Hike 2Health News:Cardiac stem cell trial seeks to treat some heart attack patients 2Health News:Cardiac stem cell trial seeks to treat some heart attack patients 3Health News:Cooling Helps Oxygen-Deprived Newborns 2Health News:Cooling Helps Oxygen-Deprived Newborns 3Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 2Health News:Boston Biotech R&D Conference to Showcase Next-Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 3Health News:Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser 2Health News:Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation 2
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,408-9) or contact custom...
... ergonomic design reduces hand fatigue, prevents injury. Dry seal technology. No cleaning, ... 1-10 Inaccuracy (%) ... Imprecision(%) ... 0.1 Dimensions: ...
... Pipetman Ultra is a fully adjustable, air-displacement ... It is the latest member of the ... characteristics: robustness, accuracy, and precision. We also ... feedback from our customers. Eight models cover ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 2-20 microliter range....
Medicine Products: